oral hypoglycaemic drugs

oral hypoglycaemic drugs

agents, e.g. biguanides, sulphonylureas, acarbose and glitazones, taken by mouth to treat diabetes mellitus, and achieve normoglycaemia
References in periodicals archive ?
So, with this background the present study is being undertaken to see the effect of vitamin D in glycaemic control in type 2 diabetic patients on oral hypoglycaemic drugs.
Group A- (Control group)- 30 Type 2 diabetic patients on oral hypoglycaemic drugs without vitamin D supplementation.
Group B- (Study group)- 30 Type 2 diabetic patients on oral hypoglycaemic drugs with vitamin D supplementation.
Participants were to have had T2D for at least two years, be older than 25 years, and have had hyperlipidaemia and hyperglycaemia at study commencement despite treatment with statins and oral hypoglycaemic drugs for at least three months.
4] Sulfonylureas have been used in diabetes mellitus for decades and are the most widely used oral hypoglycaemic drugs.
It is comparatively free of significant side effects and unlike most other oral hypoglycaemic drugs lacks a significant risk of producing hypoglycaemia, which itself can also increase cardiovascular risk.
Oral hypoglycaemic drugs vary in their mode of excretion and duration of action.
The oral hypoglycaemic drugs, diabenese, daonil and glucophage used in this study were obtained from Nigeria-German drugs, Plc (Lagos, Nigeria).
The 65s and over Anyone with a serious medical condition, particularly children with long term conditions of chronic respiratory disease, heart disease, renal disease and chronic liver disease, diabetes requiring insulin or oral hypoglycaemic drugs and immunosuppression.
Anyone with an underlying health condition including: Chronic respiratory disease, such as chronic obstructive pulmonary disease (COPD); Chronic heart disease; Chronic kidney disease, such as kidney failure; Chronic liver disease; Chronic neurological disease; Diabetes requiring insulin or oral hypoglycaemic drugs and immunosuppression.
The management of MODY is similar to the normal management of diabetes which include: change in dietary habits, regular exercising, oral hypoglycaemic drugs and insulin.
With the rapidly rising burden of diabetes in developing countries37 oral hypoglycaemic drugs deserve a special mention as well.